p53 (TP53) Rabbit Polyclonal Antibody
CAT#: TA321153
Anti-TP53 Rabbit Polyclonal Antibody
Size: 25 ul
Need it in bulk or conjugated?
Get a free quote
CN¥ 1,999.00
CN¥ 3,280.00
CN¥ 3,080.00
CN¥ 2,900.00
CN¥ 9,998.00
Specifications
Product Data | |
Applications | WB |
Recommend Dilution | WB: 500-2000 WB positive control: HT29, HepG2, Hela, 231 cell lysates |
Reactivity | Human |
Host | Rabbit |
Clonality | Polyclonal |
Immunogen | Fusion protein corresponding to a region derived from 1-233 amino acids of human tumor protein p53 |
Formulation | PBS pH7.3, 0.05% NaN3, 50% glycerol |
Concentration | lot specific |
Purification | Antigen affinity purification |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Predicted Protein Size | 44 kDa |
Gene Name | tumor protein p53 |
Database Link | |
Background | This gene encodes tumor protein p53; which responds to diverse cellular stresses to regulate target genes that induce cell cycle arrest; apoptosis; senescence; DNA repair; or changes in metabolism. p53 protein is expressed at low level in normal cells and at a high level in a variety of transformed cell lines; where it's believed to contribute to transformation and malignancy. p53 is a DNA-binding protein containing transcription activation; DNA-binding; and oligomerization domains. It is postulated to bind to a p53-binding site and activate expression of downstream genes that inhibit growth and/or invasion; and thus function as a tumor suppressor. Mutants of p53 that frequently occur in a number of different human cancers fail to bind the consensus DNA binding site; and hence cause the loss of tumor suppressor activity. Alterations of this gene occur not only as somatic mutations in human malignancies; but also as germline mutations in some cancer-prone families with Li-Fraumeni syndrome. Multiple p53 variants due to alternative promoters and multiple alternative splicing have been found. These variants encode distinct isoforms; which can regulate p53 transcriptional activity. |
Synonyms | BCC7; LFS1; P53; TRP53 |
Reference Data | |
Protein Families | Druggable Genome, Stem cell - Pluripotency, Transcription Factors |
Protein Pathways | Amyotrophic lateral sclerosis (ALS), Apoptosis, Basal cell carcinoma, Bladder cancer, Cell cycle, Chronic myeloid leukemia, Colorectal cancer, Endometrial cancer, Glioma, Huntington's disease, MAPK signaling pathway, Melanoma, Neurotrophin signaling pathway, Non-small cell lung cancer, p53 signaling pathway, Pancreatic cancer, Pathways in cancer, Prostate cancer, Small cell lung cancer, Thyroid cancer, Wnt signaling pathway |
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |